利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

98 条记录 (耗时 0.035 秒)

    Intraluminal medical devices in combination with therapeutic agents
    3.
    发明授权
    Intraluminal medical devices in combination with therapeutic agents 有权
    管腔内医疗器械与治疗剂组合

    公开(公告)号：US08747881B2

    公开(公告)日：2014-06-10

    申请号：US11131720

    申请日：2005-05-18

    申请人： Robert Falotico ,  Pallassana Narayanan

    发明人： Robert Falotico ,  Pallassana Narayanan

    IPC分类号： A61F13/00 ,  A61F2/00 ,  A61F2/06

    CPC分类号： A61F2/06 ,  A61F2/07 ,  A61L31/10 ,  A61L31/16 ,  A61L2300/41 ,  A61L2300/416 ,  A61L2300/434 ,  A61L2300/602 ,  C08L27/16 ,  C08L27/20

    摘要： Medical devices may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

    摘要翻译： 可以涂覆医疗装置以最小化或基本上消除生物体对将生物体引入医疗装置的反应。 医疗装置可以涂覆任何数量的生物相容性材料。 治疗药物，药剂或化合物可以与生物相容性材料混合并固定在医疗装置的至少一部分上。 此外，这些治疗药物，药剂和/或化合物可用于促进愈合，包括血块的形成。 此外，可以使用各种聚合物组合来控制来自可植入医疗装置的治疗药物，药剂和/或化合物的洗脱速率。

    Antithrombotic coating for drug eluting medical devices
    5.
    发明授权
    Antithrombotic coating for drug eluting medical devices 有权
    用于药物洗脱医疗器械的抗血栓涂层

    公开(公告)号：US07947302B2

    公开(公告)日：2011-05-24

    申请号：US12334849

    申请日：2008-12-15

    申请人： Robert Falotico ,  Jonathon Z. Zhao

    发明人： Robert Falotico ,  Jonathon Z. Zhao

    IPC分类号： A61F2/06 ,  A61K47/32

    CPC分类号： A61L33/0029 ,  A61L31/16 ,  A61L2300/416 ,  A61L2300/42 ,  A61L2300/61

    摘要： Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.

    摘要翻译： 可以涂覆医疗装置，特别是可植入医疗装置，以最小化或基本上消除生物体对将生物体引入医疗装置的反应。 医疗装置可以涂覆任何数量的生物相容性材料。 治疗药物，药剂或化合物可以与生物相容性材料混合并固定在医疗装置的至少一部分上。 这些治疗药物，药剂或化合物还可以进一步减少生物体对将生物体引入医疗装置的反应。 此外，这些治疗药物，药剂和/或化合物可用于促进愈合，包括血块的形成。 可以使用各种材料和涂覆方法来将药物，试剂或化合物维持在医疗装置上，直到输送和定位。

    Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury
    6.
    发明授权
    Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury 有权
    局部血管输送依托泊苷与雷帕霉素联合，以防止血管损伤后的再狭窄

    公开(公告)号：US07695731B2

    公开(公告)日：2010-04-13

    申请号：US10805722

    申请日：2004-03-22

    申请人： Robert Falotico ,  Tom Jay Parry ,  Jonathon Z. Zhao

    发明人： Robert Falotico ,  Tom Jay Parry ,  Jonathon Z. Zhao

    IPC分类号： A61F2/06

    CPC分类号： A61L31/16 ,  A61L27/34 ,  A61L27/54 ,  A61L31/10 ,  A61L2300/416 ,  A61L2300/43 ,  A61L2300/45 ,  A61L2300/608 ,  A61L2420/08

    摘要： Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

    摘要翻译： 可以涂覆医疗装置，特别是可植入医疗装置，以最小化或基本上消除生物体对将生物体引入医疗装置的反应。 医疗装置可以涂覆任何数量的生物相容性材料。 治疗药物，药剂或化合物可以与生物相容性材料混合并固定在医疗装置的至少一部分上。 这些治疗药物，药剂或化合物还可以进一步减少生物体对将生物体引入医疗装置的反应。 此外，这些治疗药物，药剂和/或化合物可用于促进愈合，包括血块的形成。 此外，可以修改装置以促进内皮化。 可以使用各种材料和涂覆方法来将药物，试剂或化合物维持在医疗装置上，直到输送和定位。 此外，可以修改用于递送可植入医疗装置的装置，以减少在展开期间损害可植入医疗装置的可能性。 医疗器械包括支架，移植物，吻合装置，血管周围包裹物，缝线和钉。 此外，可以使用各种聚合物组合来控制来自可植入医疗装置的治疗药物，药剂和/或化合物的洗脱速率。

    LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
    8.
    发明申请
    LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS 审中-公开
    与过氧化物酶体增殖物激活受体刺激物组合的mTOR抑制剂的局部血管输送

    公开(公告)号：US20090074831A1

    公开(公告)日：2009-03-19

    申请号：US11857285

    申请日：2007-09-18

    申请人： Robert Falotico ,  Andrew Sheung-King Luk ,  Theodore L. Parker ,  Jonathon Z. Zhao ,  Lei Zhao

    发明人： Robert Falotico ,  Andrew Sheung-King Luk ,  Theodore L. Parker ,  Jonathon Z. Zhao ,  Lei Zhao

    IPC分类号： A61K9/00 ,  A61K31/427 ,  A61K31/4439

    CPC分类号： A61L31/16 ,  A61L31/10 ,  A61L2300/416 ,  A61L2300/432 ,  A61L2300/45 ,  A61L2300/602

    摘要： Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the prevention of thrombosis. The drugs, agents, and/or compounds may also be utilized to treat specific disorders, including vulnerable plaque, and atherosclerosis in type 2 diabetic patients. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

    摘要翻译： 可以涂覆医疗装置，特别是可植入医疗装置，以最小化或基本上消除生物体对将生物体引入医疗装置的反应。 医疗装置可以涂覆任何数量的生物相容性材料。 治疗药物，药剂或化合物可以与生物相容性材料混合并固定在医疗装置的至少一部分上。 这些治疗剂或化合物还可以进一步减少生物体对将生物体引入医疗装置的反应。 此外，这些治疗药物，药剂和/或化合物可用于促进愈合，包括预防血栓形成。 药物，药剂和/或化合物也可用于治疗2型糖尿病患者中的特定疾病，包括易损斑块和动脉粥样硬化。 治疗剂也可以递送到疾病部位的区域。 在区域递送中，液体制剂可能是期望的，以增加特定药物的功效和递送能力。 此外，可以修改装置以促进内皮化。 可以使用各种材料和涂覆方法来将药剂或化合物维持在医疗装置上，直到被输送和定位。 此外，可以修改用于递送可植入医疗装置的装置，以减少在展开期间损害可植入医疗装置的可能性。 此外，可以使用各种聚合物组合来控制来自可植入医疗装置的治疗药物，药剂和/或化合物的洗脱速率。

    COATING FOR A MEDICAL DEVICE HAVING AN ANTI-THROMBOTIC CONJUGATE
    9.
    发明申请
    COATING FOR A MEDICAL DEVICE HAVING AN ANTI-THROMBOTIC CONJUGATE 审中-公开
    用于具有抗凝血药物的医疗装置的涂层

    公开(公告)号：US20080200421A1

    公开(公告)日：2008-08-21

    申请号：US11677190

    申请日：2007-02-21

    申请人： Jonathon Z. Zhao ,  Robert Falotico

    发明人： Jonathon Z. Zhao ,  Robert Falotico

    IPC分类号： A61K31/727 ,  A61P41/00 ,  A61P7/02

    CPC分类号： A61L33/0029 ,  A61L31/10 ,  A61L31/148 ,  A61L31/16 ,  A61L2300/42

    摘要： A conjugate between an anti-thrombotic agent and a bioabsorbable polymer is provided. In addition, a method is provided for applying a coating comprising an anti-thrombotic agent and a bioabsorbable polymer conjugate to at least a portion of an implantable device to prevent or reduce the formation of thrombosis on the surface of the device. A first or sub-layer of the coating is prepared by mixing a polymeric material and a biologically active agent with a solvent, thereby forming a homogeneous solution. A second or outer layer comprises an anti-thrombotic heparin-bioabsorbable polymer conjugate. This coating may be applied over the inner drug-containing layers using, for example, a dip coating or spray coating process. After drying, the anti-thrombotic heparin bioabsorbable polymer conjugate remains in the outer layer of the coating, allowing agent from the inner layer to be eluted there through. In addition, the outmost layer prevents the formation of thrombosis, and also serves to modulate the release kinetics of the agent(s) contained within an inner layer(s) of the coating.

    摘要翻译： 提供抗血栓形成剂和生物可吸收聚合物之间的缀合物。 此外，提供了一种方法，用于将包含抗血栓形成剂和生物可吸收聚合物缀合物的涂层施用于至少一部分可植入装置，以防止或减少装置表面上的血栓形成。 通过将聚合材料和生物活性剂与溶剂混合制备涂层的第一层或次层，由此形成均匀溶液。 第二层或外层包含抗血栓形成肝素 - 生物可吸收聚合物缀合物。 可以使用例如浸涂或喷涂方法将该涂层施加在内含药层上。 干燥后，抗血栓形成的肝素生物可吸收聚合物共轭物保留在涂层的外层，允许来自内层的试剂在那里被洗脱。 此外，最外层防止血栓形成，并且还用于调节包含在包衣内层中的药剂的释放动力学。